SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-021604
Filing Date
2020-08-12
Accepted
2020-08-12 16:00:50
Documents
2
Period of Report
2020-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea125284-8k_immucell.htm 8-K 23385
2 PRESS RELEASE OF IMMUCELL CORPORATION DATED AUGUST 12, 2020 ea125284ex99-1_immucell.htm EX-99.1 54480
  Complete submission text file 0001213900-20-021604.txt   78955
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 201095419
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences